Skip to main content
. 2011 Jun 23;7:391–398. doi: 10.2147/NDT.S20589

Figure 1.

Figure 1

Study participants.

Notes: All patients who received at least one injection of risperidone long-acting injection and had at least one postbaseline efficacy assessment (intention-to-treat population) were included in the efficacy analysis (ITTe). The safety population comprised all patients who received at least one injection, regardless of efficacy measurement status (ITTs).